Jason Kropp

JASON KROPP advises emerging and growth-stage companies, venture and growth equity investors, and mature public and private businesses on a wide range of strategic transactions and corporate matters. His practice focuses on the life sciences, biotech, medical device, software, and technology industries, where he counsels clients from formation through exit, including financings, M&A, and other mission-critical deals. Jason represents both companies and investors in early- and late-stage venture capital and growth financings, often serving as outside general counsel to his clients. He regularly works with management teams and boards navigating complex equity structures, board and governance matters, and strategic transactions across the corporate lifecycle. Jason has advised on more than 500 private company financing transactions, resulting in more than US$32 billion of proceeds.